Remove Exercises Remove Healthcare Remove Meeting Remove Sales
article thumbnail

The Belgian Data Protection Authority Publishes Recommendation Concerning Data Processing for Direct Marketing Purposes

HL Chronicle of Data Protection

The Recommendation applies to all kinds of promotions, including sales and advertising, and is not limited to promotions of a commercial nature. Fulfilment of Transparency Obligations and making sure that Data Subjects can exercise their rights. This will enable Data Subjects to effectively exercise their rights. How to Comply?

article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

The CCPA imposes obligations on for-profit “businesses” that meet specific threshold requirements. Determining what is medical information and who is a provider of health care under the CMIA have long been complicated assessments for health and life science companies such as pharmaceutical and device manufacturers.

Privacy 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

The CCPA imposes obligations on for-profit “businesses” that meet specific threshold requirements. Determining what is medical information and who is a provider of health care under the CMIA have long been complicated assessments for health and life science companies such as pharmaceutical and device manufacturers.

Privacy 40
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

The CCPA imposes obligations on for-profit “businesses” that meet specific threshold requirements. Determining what is medical information and who is a provider of health care under the CMIA have long been complicated assessments for health and life science companies such as pharmaceutical and device manufacturers.

Privacy 40